BCL2 and B-cell chronic lymphocytic leukemia: A comparison of BCL2 levels within the CLL clonal population (U-CLL950) before in vitro activation versus after 5d stimulation with synergistic ODN + IL15 revealed a pronounced decline (71%) associated with stimulation (Figure 1A).